17-6690925-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_177550.5(SLC13A5):c.1291G>A(p.Val431Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000596 in 1,609,696 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_177550.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC13A5 | NM_177550.5 | c.1291G>A | p.Val431Met | missense_variant | 10/12 | ENST00000433363.7 | NP_808218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC13A5 | ENST00000433363.7 | c.1291G>A | p.Val431Met | missense_variant | 10/12 | 1 | NM_177550.5 | ENSP00000406220 | P1 | |
ENST00000634558.1 | n.662+898C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152206Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000267 AC: 66AN: 247572Hom.: 1 AF XY: 0.000277 AC XY: 37AN XY: 133622
GnomAD4 exome AF: 0.0000542 AC: 79AN: 1457372Hom.: 0 Cov.: 31 AF XY: 0.0000580 AC XY: 42AN XY: 724500
GnomAD4 genome AF: 0.000112 AC: 17AN: 152324Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74488
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2018 | The p.V431M variant (also known as c.1291G>A), located in coding exon 10 of the SLC13A5 gene, results from a G to A substitution at nucleotide position 1291. The valine at codon 431 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Developmental and epileptic encephalopathy, 25 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at